(Boursier.com) — The annual turnover of Lumibird amounts to 162.5 ME in 2021, up 28% in published data and +10% in pro forma.
The change at constant exchange rate is +29%, after neutralizing negative exchange rate effects for €1.5 million.
Pro forma, annual growth is strong in its two divisions, with +11% in Photonics and +9% in Medical.
The company reaffirms its objectives of doubling its published turnover between 2020 and 2023 under the effect of organic and external growth, and of an EBITDA margin growing in a range of 20% to 25% from 2021.
©2022 Boursier.com